22 results
20-F/A
2022 FY
FRES
Fresh2 Group Ltd
25 Mar 24
Annual report (foreign) (amended)
4:02pm
in both the United States and globally, all of which were unfavorably impacted by the COVID-19 pandemic. To the extent that business conditions … the coronavirus a pandemic on March 11, 2020, given its threat beyond a public health emergency of international concern that the organization had declared
20-F/A
2022 FY
FRES
Fresh2 Group Ltd
9 Jan 24
Annual report (foreign) (amended)
4:24pm
as current market conditions in both the United States and globally, all of which were unfavorably impacted by the COVID-19 pandemic. To the extent … Organization labeled the coronavirus a pandemic on March 11, 2020, given its threat beyond a public health emergency of international concern
424B5
FRES
Fresh2 Group Ltd
6 Dec 23
Prospectus supplement for primary offering
5:23pm
of the COVID-19 Pandemic
Since December 2019, there has been an outbreak of a novel strain of coronavirus (COVID-19) in China and around the world … a pandemic on March 11, 2020. In response to this pandemic, China, the United States and many other countries and jurisdictions have taken, and may continue
6-K
EX-99.2
FRES
Fresh2 Group Ltd
4 Dec 23
Report of Foreign Private Issuer
6:43am
, the World Health Organization declared COVID-19 as a “Public Health Emergency of International Concern”. The COVID-19 pandemic has resulted … in significant economic disruption. During the pandemic, global travel and supply chains adversely impacted global commercial activity. Even though the initial
424B5
FRES
Fresh2 Group Ltd
25 Sep 23
Prospectus supplement for primary offering
9:28am
developed test in the future.
Impact of the COVID-19 Pandemic
Since December 2019, there has been an outbreak of a novel strain of coronavirus (COVID-19 … labeled the coronavirus a pandemic on March 11, 2020. In response to this pandemic, China, the United States and many other countries
6-K
EX-99.2
amym4ngx7f u85ey
21 Aug 23
Report of Foreign Private Issuer
4:01pm
6-K
EX-1.1
wjprvul4pai
4 Apr 23
Report of Foreign Private Issuer
5:24pm
424B5
n7tvi8n
4 Apr 23
Prospectus supplement for primary offering
5:23pm
424B5
9ff1az
12 Nov 21
Prospectus supplement for primary offering
5:23pm
6-K
EX-99.2
0dorcu8p
12 Oct 21
Current report (foreign)
4:31pm
6-K
EX-99.1
13jqbkxzr80zr0jtajzn
12 Oct 21
Current report (foreign)
4:31pm
424B5
1tkkqwqvmz5dfgwue
22 Jul 21
Prospectus supplement for primary offering
12:57pm
F-3
swc05xz3 qb9wel
28 May 21
Shelf registration (foreign)
4:32pm
6-K
EX-99.1
nwlqg0s80uijn0i9p
30 Apr 21
Current report (foreign)
5:02pm
F-1/A
7vb69u
14 Oct 20
Registration statement (foreign) (amended)
4:06pm
F-1
jtbms
30 Sep 20
Registration statement (foreign)
4:05pm
6-K
EX-99.1
mya2br26ohcrwtyo 8x0
10 Sep 20
AnPac Bio Reports First Six Months of 2020 Financial Results
8:22am